9th CAR-TCR Summit

Temas de la conferencia
The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T treatment, and further approvals set for this year, 2024 will be pivotal to demonstrate the clinical benefit of cell therapies and advance breakthroughs in solid tumors and autoimmunity.

Organizador profesional (PCO)
Hanson Wade

Observaciones
Brochure: https://go.evvnt.com/2431289-3?pid=4832

Speakers: Carl June, Professor in Immunotherapy, Director, Center for Cellular Immunotherapies, University of Pennsylvania, and more

https://go.evvnt.com/2431289-2?pid=4832

Ms. Ellie Saunders